@@@@@@@@@@@@@@@@@@@@@@@@@@@@@@
Group D-10 ‰»Šw\‘’@(Chemical Structure)  
œ 1,1-Dimethylhydrazine (UDMHj i1,1-ƒWƒƒ`ƒ‹ƒqƒhƒ‰ƒWƒ“)@
@@  CASF 57-14-7@Jet fuels@@MW. 60.12
AM Sal. Min (?)
›
1-4)
AM Sal/E. coli Min ( 1.25 mg/plate, -S9) › 16)
HMA E. coli Min (?)
›
5)
MB ƒΙ-Prophage/
E. coli
Max(?)
 
6)
MLA L5178Y Min (?)
›
2, 7)
SM CHO Min (?)
›
8)
UDS Rat/Hepatocytes Min (?)
›
5)
SCE CHO Min (?)
›
9)
CA CHO Min i0.025 mg/ml, -‚r9), 24h
›
9)
CA CHL/IU Min i0.025mg/ml, -S9j, 24-48h; D20= 0.013; TR= 640

10)
CA CHL/IU Min i0.04 mg/ml, -S9j, 24h; D20= 0.03; TR= 680 › 17)
MNv Dogs Max(?)
 
11)
DLv Mice Max(?)
 
2, 12)
SPMv Mice Min (?)
›
13)
MNv Mice/Liver Max(?), (96h)
 
14)
DNA Rat/Lung, Liver Min (?)
›
15)
1) Rogan EG., et al.: Mutation Res., 102, 413-424(1982)
2) Matheson D., et al: Mutation Res., 53, 93-96 (1978)
3) Tosk J., et al.: Mutation Res., 66, 247-252 (1979)
4) Parodi D., et al.: Cancer Res.,41, 1469-1482 (1981)
5) Lingens F.: Z. Naturforsch., 19B, 151-156 (1964)
6) Heinemann B.: Appl. Microbiol., 21, 726-731 (1971)
7) Rogers AM., et al.: Mutation Res., 89, 321-328 (1981)
8) Kuszynski C., et al.: Environ. Mutagen., 3, 323-324 (1981)
9) Calandra TD., et al.: Environ. Mol. Mutagen., suppl. 15, 12 (1990)
10) Ishidate MJr.(Ed.): Data Book, Chromosomal Aberration Test: In vitro, LIC, Tokyo/Elsvier, Amsterdam (1988)
11) Beng RO & Beltz PA.: Environ. Mutagen. 2, 312-313 (1980)
12) Epstein SS., et al.: Toxicol. Appl. Pharmacoll, 23, 288-325 (1972)
13) Wyrobeck AJ. & Bruce WR.: Proc. Natl Acad. Sci., 72, 4425-4429 (1975)
14) Cliet I.., et al.: Mutation res., 216, 321-326 (1989)
15) Parodi S., et al.: Proc. Am. Assoc. Cancer Res., 21, 99 (1980)
16)
Ministry of labour, Japan: Mutagen. Test. Data of Exist. Chem. Subst., JETOC(Ed.), pp.197 (1996)  (Tables in English)
17) Ministry of labour, Japan: Mutagen. Test. Data of Exist. Chem. Subst., JETOC(Ed.),Suppl., pp.282 (1997)  (Tables in English)

IARC Carcinogenicity CriteriaF
Group 2B
@(Possibly carcinogenic in humans)

œ 1,2-Dimethylhydrazine 2-HCl
@@@ 306-37-6 @Industry@@ 133.02
CA CHL/IU Max ( 1.0 mg/ml)
 
1)
1) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test In vitro, LIC, Tokyo (1998) (Tables in English)

œ Dimethylmalonate (ƒ}ƒƒ“Ž_ƒWƒƒ`ƒ‹j@
@  
108-59-8 Industry@ 132.12
AM Sal./E.coli Max ( 5.0 mg/plate, }S9)
 
1)
1) Ministry of Labour, Japan: Mutagen. Test. Data of Exist. Chem. Subst., Suppl. 2, JETOC(Ed.), (2000), pp. 203  (Tables in English)

œ Dimethyl 2,6-naphthalenedicarboxylate
i2,6-ƒiƒtƒ^ƒŒƒ“ƒWƒJƒ‹ƒ{ƒLƒV|ƒƒ`ƒ‹ƒGƒXƒeƒ‹j
@@@ 840-65-3@Industry @ 244.25
AM Sal. Max i5.0 mg/plate,}S9)
 
1)
CA CHL/IU Max ( 1.2 mg/ml; }S9), 6-18h
 
1)
‚Pj Ministry of Health, labour & Welfare, Japan (Ed): Tox Test. Re.p of Environ. Chemicals, Vol. 5 (1997)  (Tables in English)

œ Dimethylnitrosamine (DEN) iƒWƒƒ`ƒ‹ƒjƒgƒƒTƒ~ƒ“j(See also N-5)
@@ @ 62-75-9@labouratory@ 74.08
REC Sal./E. coli Min (5 x 10-2 ƒΚg/well
›
1)
AM Sal. Min ( 50 mg/ml, +S9)
›
2)
CA Human LY Min ( 50 ƒΚM, +S9)
›
3)
CA CHO Min ( 27mM, +S9)
›
4)
CA CHL/IU Min ( 0.5 mg/ml, +S9), 6-18h; D20= 0.53, TR= 63
›
5)
SCE Human LY Max ( 500 ƒΚM, -S9)
 
6)
SCE CHO Min ( 2.7mM, +S9)
›
4)
SM V79/8AG Min (10 mM, +S9)
›
7)
UDS HeLa cells Min (10 -4M +S9)
›
8)
CT BHK21c113 (Soft agar method), Min (?)
›
9)
CAv Rat/LY Min ( 30 mg/kg), ip
›
10)
‚Pj Ichinotsubo D. et al, : Mutation Res., 46, 53-62 (1977)
2) Gletten F. et al.: Mutation Res., 28 113-122 (1975)
3) Binboes D & Greim H: Mutation Res., 35, 155-160 (1976)
4) Natarajan AT, et al,: Mutation Res., 37. 83-90 (1976)
5) ‚h‚“‚ˆ‚‰‚„‚‚”‚…@‚l‚i‚’Di‚d‚„Dj: ‚c‚‚”‚@‚a‚‚‚‹C‚b‚ˆ‚’‚‚‚‚“‚‚‚‚Œ@‚`‚‚‚…‚’‚’‚‚”‚‰‚‚Ž ‚s‚…‚“‚” in vitro, LIC/Tokyo & Elsevier/Amsterdam (1988)
6) Craig-Holmes AP & Shaw MW: Mutation Res., 46, 375-384 (1977)
7) Kuroki T, et al,: Cncer Res., 37, 1044-1050 (1977)
8) Martin CN. et al,: Cancer Res., 38, 2621-2627 (1978)
9) Styles JA.: Br. J. Cancer, 37, 931-936 (1978)
10) Lilly LJ, et al.: Nature, 258, 611-612 (1975)


œ 1,4-Dimethyl-2-(1-phenylethyl) benzene i1,4-ƒWƒƒ`ƒ‹-2-(1-ƒtƒFƒjƒ‹|ƒGƒ`ƒ‹)ƒxƒ“ƒ[ƒ“j
@@@@
6165-51-1@Industry @ 210.31
AM Sal. Max i5.0 mg/plate,}S9)
 
1)
CA CHL/IU Max ( 2.1mg/ml; +S9), 6-18h
 
1)
‚PjMinistry of Health, labour & Welfare, Japan (Ed): Tox.Test.Rep. Environ. Chem., Vol. 9 (2002)(Tables in English)

œ N,N'-Dimethyl-p-phenylenediamine
@@@ 99-98-9@Medicine@@@ 136.20
AM Sal. Min (?)
›
1)
CA CHL/IU Min ( 0.01 mg/ml, -S9), 24h@D20= 0.01; TR= 900
›
2)
1) Zeiger E. et al.: Environ. Mol. Mutagen., 19 (Suppl, 21)2-141 (1992)@
2) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test In vitro, LIC, Tokyo (1998) (Tables in English)

œ 3,4-Dimethylphenyl-N-methylcarbamate (MPMC)
@@@ 2425-10-7@Pesticide@@ 179.22
CA CHL/IU Min ( 0.125 mg/ml, -S9), 48h@D20= 0.34 (No exchanges)
›
1)
1) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test in vitro LIC, Tokyo (1998)  (Tables in English)

œ 3,4-Dimethylphenyl-N-nitroso-N-methylcarbamate
@@@
58139-33-6@labouratory@ 208.22
CA CHL/IU Min ( 0.015 mg/ml, -S9), 24h@D20= 0.009; TR= 5100

1)
1) Ishidate MJr (Ed.): Data Book of Chromosomal Aberration Test in vitro LIC/Tokyo, Elsevier/ Amsterdam (1988)

œ O,O-Dimethyl phosphorochlorideothioate
    2524-03-0@@Industry @ 160-56
AM Sal. Min i0.0781 mg/plate,+S9), spa=1.05 x 103(E. coli)
 
1)
CA CHL/IU Min ( 0.03 mg/ml; -S9), 6-18h; Poly also
 
1)
1) Ministry of labour, Japan: Mutagen. Test. Data of Exist. Chem. Subst., JETOC(Ed.), Suppl. 2, pp. 50 (2000)  (Tables in English)
1) Ministry of labour, Japan: Mutagen. Test. Data of Exist. Chem. Subst., JETOC(Ed.), Suppl. 3, pp. 232 (2005) (Tables in English)

œ Dimethylphthalate
(DEP)iƒWƒƒ`ƒ‹ƒtƒ^ƒŒ[ƒgj
@@@131-11-3@@Industry @ 194.19

US-NTP Genotoxicity ScreeningF

› Ames TestF@
 
› MLAF@ 
› CA Test with CHO CellsF@ 
›
SCE Test with CHO CellsF@ 

œ 2,2-Dimethyl-1,3-propanediol@i2,2-ƒWƒƒ`ƒ‹-1C3-ƒvƒƒpƒ“ƒWƒI[ƒ‹j
@@@@ 126-30-7@Industry @ 104.15
AM Sal./E. coli Max i 5.0 mg/plate,}S9)
›
1, 2)
CA CHL/IU Max ( 1.0 mg/ml; }S9), 6-18h
›
2)
1) Ministry of labour, Japan: Mutagen. Test. Data of Exist. Chem. Subst., JETOC(Ed.), Suppl. 2, pp. 54 (2000)  (Tables in English)
2jMinistry of Health, labour & Welfare, Japan (Ed): Tox.Test. Rep. Environ. Chemicals, Vol. 1 (1994) (Tables in English)

œ Dimethyl sulfate@i—°Ž_ƒWƒƒ`ƒ‹j
@@
77-78-1@Industry@@ 126.1
AM Sal. Min ( 0.04 mg/ml, -S9) › 4)
CA Vicia fava
(ƒ\ƒ‰ƒ}ƒ)
Min ( 10-4M)
›
1)
CA CHL/IU Min ( 0.04 mg/ml, -S9); D20= 0.027; TR= 860 › 2)
SCE Hum. Fb Min ( 1.5 ƒΚ‚‡/ml, -S9) › 5)
SM CHO Min (2.5 ƒΚ‚‡/ml, -S9) › 6, 7)
SM CHO/8TG Min ( 10 ƒΚM)
›
3)
SM V79 Min ( 8ƒΚg/ml, -S9) › 7)
UDS Rat hepatocytes Min ( 12.6 ƒΚg/ml, -S9) › 3)
CAv Rats, BM Min ( 0.35 mg/kg) › 7)
CAv Mice, BM Min ( 3.85 ppm, ih) › 7)
DLv Mice Max (?)   5, 7)
SLRLv Drosophila Min (?) › 5)
DNAv Mice, testis Min (?) › 5)
‚Pj Strelid S. & Kihlman A.: Hereditas, 88, 27-33 (1978)
2) Ministry of labour, Japan: Mutagen. Test. Data of Exist. Chem. Subst., JETOC(Ed.), pp. 480 (1996)  (Tables in English)
3) Cough DB., et al.: Mutation Res., 57, 217-224(1978)
4) Skopek TR. et al., Proc. Natl., Acad. Sci, USA, 75, 4465-4469 (1978)
5) Hoffmann GR, Mutation Res., 75, 63-129 (1980)
6) Tan EL, J. Toxicol. and Environ. Health,  11, 373-380 (1983)
7) IPCS/WHO, Environ. Health Criteria, 48 (1985)

@IARC Carcinogenicity CriteriaF
@Group 2A
(Probably carcinogenic in humans)

yNotez (Cited from IARC Monograph, Suppl., 6 (1987)
@@It is an alkylating agent. No data were available on the genetic and related effects of this compound in humans.
@@It induced both structural and numerical CAs in bone-marrow cells of rats treated in vivo and chromatid breaks in mouse embryos treated transplacentally. It alkylated DNA in rats treated in vivo and in cultured rodent cells. It induced SCEs, UDS and DNA strand breaks in human and rodent cells in vitro, and CAs and mutation in cultured rodent cells. It induced SLRL mutations in Drosophila and mutation and mitotic recombination in yeast. Conflicting results were obtained for CAs and mutation in plants. It induced mutation and DNA damage in bacteria.

œ Dimethyl terephthalate iƒWƒƒ`ƒ‹ƒeƒŒƒtƒ^ƒŒ[ƒgj (p-ƒtƒ^ƒ‹Ž_ƒWƒƒ`ƒ‹;@i1,4-ƒxƒ“ƒ[ƒ“-
@@@ƒWƒJƒ‹ƒ{ƒLƒVŽ_ƒWƒƒ`ƒ‹ƒGƒXƒeƒ‹j

@@@@ 120-61-6@Labolatory@@ 194.19
AM Sal./E.coli Max ( 5.0 mg/platae, }S9)
 
1)
AM Sal. Max ( 3.3 mg/platae, }S9)   2-4)
MLA Y5178Y Max ( 0.1 mg/ml, }S9)   5)
CA CHL/IU Max ( 2.0/ml; -S9), 24-48h@(No data for +S9)   6, 7)
CA CHO Max ( 10 mg/ml, }S9)   8)
MN Human lym. Max ( 0.5mg/ml; -S9), for 72h@(No data for +S9)
 
3, 4)
SCE CHO Max ( 10 mg/ml, }S9)   8)
UDS HeLa cells Max ( 5 mg/ml, }S9)   3, 4)
CT Ham. SA/SHE Max ( 1 mg/ml, -S9, (No data for +S9)   8)
‚PjMinistry of labour, Japan: Mutagen. Test. Data of Exist. Chem. Subst., JETOC(Ed.), pp. 174 (1996)  (Tables in English)
2) Zeiger E., et al., Environ Health Perspect., 45, 99-101 (1982)
3) Lerda DE, Int. J. Environ Health Res., 6, 125-130 (1996)
4) Monarca S., et al., Mutation Res., 262, 85-92 (1991)
5) Myhr BC & Caspury WJ., Environ. Mol Mutagen., 18, 51-83 (1991)
6) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test In VitroLIC, Tokyo (1998) (Tables in English)

7) Ishidate MJr. et al., Mutation Res., 195, 151-213 (1988)
8) Loveday KS., et al., Environ. Mol Mutagen., 16, 272-303 (1990)
9) Heidelbergaer C et al., Mutation Res., 114, 283-285 (1983)

œ N,N''-Dimethyltriptamine@iN,N'-ƒWƒƒ`ƒ‹ƒgƒŠƒvƒ^ƒ~ƒ“j@@
@@@@ 61-50-7@Industry /Solvent@@ 188.27
AM Sal. Max (?)
 
1)
CA CHL/IU Max ( 0.125 mg/ml; -S9), 24-48h@(No data for +S9)
 
2)
‚Pj (?)
2) Sofuni T. (Ed.): Data Book of Chromosomal Aberration Test in vitro LIC, Tokyo (1998) (Tables in English)

œTop Page@iƒgƒbƒvƒy[ƒWj
œAbbreviation @iΘ—ͺ‹L†j@
œMutagenicity @i•ΟˆΩŒ΄«j
œTest Systems@(ŽŽŒ±–@‚ΜŽν—ށj
œTechnical Problems@i‹Zp“I–β‘θ“_j
œList of@Compoundsi‰»‡•¨ƒŠƒXƒgj
œEvaluation of Results@iŽŽŒ±Œ‹‰Κ‚Μ•]‰Ώj